WIXOM, Mich., June 29, 2011 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron-deficiency anemia, today announced that the Company was added to the Russell 2000® Index at the close of market on June 24, 2011 as part of the annual reconstitution of Russell indexes. The Russell 2000® Index measures the performance of the small-cap segment of the U.S. equity universe.
